Boston Scientific, Cordis Face Off Over Damages

Law360, New York (October 1, 2007, 12:00 AM EDT) -- Boston Scientific Corp. is fighting a bid by rival medical device maker Cordis Corp. to enforce a damages stipulation in the companies’ infringement battle over heart stents, arguing that the Johnson & Johnson subsidiary is making an eve-of-trial attempt to limit Boston Scientific’s available damages.

In a memorandum and opposition filed Monday in the U.S. District Court for the Northern District of California, Boston Scientific accused Cordis of trying to undo an agreement reached by the parties in July.

“Cordis now claims that the purpose of...
To view the full article, register now.